Pfizer Dividends Paid vs Change In Cash Analysis

PFE Stock  USD 25.33  0.10  0.40%   
Pfizer financial indicator trend analysis is much more than just breaking down Pfizer Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pfizer Inc is a good investment. Please check the relationship between Pfizer Dividends Paid and its Change In Cash accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Dividends Paid vs Change In Cash

Dividends Paid vs Change In Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pfizer Inc Dividends Paid account and Change In Cash. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Pfizer's Dividends Paid and Change In Cash is -0.3. Overlapping area represents the amount of variation of Dividends Paid that can explain the historical movement of Change In Cash in the same time period over historical financial statements of Pfizer Inc, assuming nothing else is changed. The correlation between historical values of Pfizer's Dividends Paid and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Dividends Paid of Pfizer Inc are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of Dividends Paid i.e., Pfizer's Dividends Paid and Change In Cash go up and down completely randomly.

Correlation Coefficient

-0.3
Relationship DirectionNegative 
Relationship StrengthInsignificant

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Change In Cash

Most indicators from Pfizer's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pfizer Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
At present, Pfizer's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 87.3 B, whereas Tax Provision is projected to grow to (1.1 B).
 2021 2022 2023 2024 (projected)
Gross Profit50.5B66.0B28.8B30.4B
Total Revenue81.3B100.3B58.5B39.5B

Pfizer fundamental ratios Correlations

0.850.70.880.770.840.820.770.250.970.560.440.540.20.930.730.6-0.120.980.710.640.350.870.840.870.91
0.850.610.860.410.610.990.770.060.930.370.00.180.140.840.540.8-0.360.910.710.210.50.840.610.810.71
0.70.610.870.520.580.610.79-0.070.70.840.160.340.340.440.590.72-0.440.640.920.36-0.120.490.580.890.54
0.880.860.870.590.730.850.9-0.010.910.680.120.370.210.710.730.74-0.470.880.840.370.350.720.730.960.78
0.770.410.520.590.920.370.550.30.660.670.640.720.250.660.870.20.080.680.460.860.210.550.920.620.81
0.840.610.580.730.920.580.630.240.790.620.410.720.240.760.950.31-0.050.80.570.710.370.671.00.720.87
0.820.990.610.850.370.580.79-0.060.910.36-0.070.110.110.790.520.83-0.440.880.710.150.510.810.580.80.68
0.770.770.790.90.550.630.79-0.240.820.680.050.130.10.60.70.79-0.710.760.840.280.280.540.630.920.78
0.250.06-0.07-0.010.30.24-0.06-0.240.14-0.050.50.580.210.350.09-0.270.650.23-0.10.470.060.260.24-0.020.16
0.970.930.70.910.660.790.910.820.140.560.220.410.140.910.70.71-0.260.980.760.440.420.90.790.90.86
0.560.370.840.680.670.620.360.68-0.050.560.170.390.340.280.640.52-0.340.460.760.37-0.120.360.620.760.45
0.440.00.160.120.640.41-0.070.050.50.220.170.550.060.440.29-0.170.480.350.00.91-0.130.210.410.130.48
0.540.180.340.370.720.720.110.130.580.410.390.550.480.460.61-0.220.460.460.240.730.050.410.720.350.52
0.20.140.340.210.250.240.110.10.210.140.340.060.480.040.190.10.130.110.320.24-0.250.080.240.20.07
0.930.840.440.710.660.760.790.60.350.910.280.440.460.040.610.490.030.960.510.60.470.890.760.680.87
0.730.540.590.730.870.950.520.70.090.70.640.290.610.190.610.31-0.260.70.580.610.390.490.950.70.83
0.60.80.720.740.20.310.830.79-0.270.710.52-0.17-0.220.10.490.31-0.640.620.82-0.030.120.560.310.760.41
-0.12-0.36-0.44-0.470.08-0.05-0.44-0.710.65-0.26-0.340.480.460.130.03-0.26-0.64-0.17-0.530.34-0.170.05-0.05-0.48-0.21
0.980.910.640.880.680.80.880.760.230.980.460.350.460.110.960.70.62-0.170.680.550.460.890.80.840.9
0.710.710.920.840.460.570.710.84-0.10.760.760.00.240.320.510.580.82-0.530.680.22-0.10.530.570.890.57
0.640.210.360.370.860.710.150.280.470.440.370.910.730.240.60.61-0.030.340.550.220.030.380.710.380.7
0.350.5-0.120.350.210.370.510.280.060.42-0.12-0.130.05-0.250.470.390.12-0.170.46-0.10.030.430.370.20.43
0.870.840.490.720.550.670.810.540.260.90.360.210.410.080.890.490.560.050.890.530.380.430.670.730.68
0.840.610.580.730.921.00.580.630.240.790.620.410.720.240.760.950.31-0.050.80.570.710.370.670.720.87
0.870.810.890.960.620.720.80.92-0.020.90.760.130.350.20.680.70.76-0.480.840.890.380.20.730.720.76
0.910.710.540.780.810.870.680.780.160.860.450.480.520.070.870.830.41-0.210.90.570.70.430.680.870.76
Click cells to compare fundamentals

Pfizer Account Relationship Matchups

Pfizer fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets167.5B154.2B181.5B197.2B226.5B237.8B
Short Long Term Debt Total52.1B39.8B38.4B35.8B75.0B78.8B
Total Current Liabilities37.3B25.9B42.7B42.1B47.8B50.2B
Total Stockholder Equity63.1B63.2B77.2B95.7B89.0B46.9B
Property Plant And Equipment Net14.0B13.9B14.9B16.3B18.9B11.3B
Net Debt50.8B36.5B35.1B34.5B72.2B75.8B
Retained Earnings97.7B96.8B103.4B125.7B118.4B124.3B
Cash1.3B1.8B1.9B416M2.9B2.0B
Non Current Assets Total134.7B119.2B121.8B145.9B183.2B192.3B
Non Currrent Assets Other4.5B4.6B7.7B13.2B9.1B5.3B
Cash And Short Term Investments9.8B12.2B31.1B22.7B12.7B14.9B
Net Receivables12.1B11.2B15.7B14.5B11.2B8.7B
Common Stock Shares Outstanding5.7B5.6B5.7B5.7B5.7B5.7B
Liabilities And Stockholders Equity167.5B154.2B181.5B197.2B226.5B237.8B
Non Current Liabilities Total66.7B64.8B61.3B59.2B89.4B93.9B
Inventory8.3B8.0B9.1B9.0B10.2B5.2B
Other Current Assets2.6B3.4B3.8B5.0B9.3B9.7B
Other Stockholder Equity(23.4B)(22.3B)(20.8B)(22.2B)(21.9B)(20.8B)
Total Liab104.0B90.8B104.0B101.3B137.2B144.1B
Property Plant And Equipment Gross14.0B28.4B30.0B31.4B35.0B36.7B
Total Current Assets32.8B35.1B59.7B51.3B43.3B32.2B
Short Term Debt16.2B2.7B2.2B2.9B10.9B5.7B
Intangible Assets35.4B28.5B25.1B43.4B64.9B68.1B
Property Plant Equipment14.0B13.9B14.9B16.3B18.9B11.3B
Accounts Payable4.2B4.3B5.6B6.8B6.7B7.0B
Accumulated Other Comprehensive Income(11.6B)(11.7B)(5.9B)(8.3B)(8.0B)(7.6B)
Common Stock Total Equity468M470M473M476M478M474.0M
Short Term Investments8.5B10.4B29.1B22.3B9.8B9.3B
Capital Stock468M470M473M476M478M474.0M
Common Stock468M470M473M476M478M474.0M
Other Liab29.7B26.6B22.6B23.3B26.9B22.1B
Other Assets4.2B4.3B5.6B6.8B6.7B5.0B
Long Term Debt36.0B37.1B36.2B32.9B60.5B63.5B
Good Will58.7B49.6B49.2B51.4B67.8B40.7B
Treasury Stock(110.8B)(111.0B)(111.4B)(114.0B)(114.5B)(108.8B)
Current Deferred Revenue5.8B6.3B3.1B2.5B2.7B3.9B
Net Tangible Assets(30.9B)63.2B77.2B95.7B89.0B93.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Dividend Share
1.67
Earnings Share
0.75
Revenue Per Share
10.493
Quarterly Revenue Growth
0.312
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.